iGMDRD135
Canonical SMILES: C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
InChI: InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
InChI Key: GOTYRUGSSMKFNF-UHFFFAOYSA-N
Drug Class:
Acids, CarbocyclicAngiogenesis InhibitorsAngiogenesis Modulating AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCarboxylic AcidsGrowth InhibitorsGrowth SubstancesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHeterocyclic Compounds, 2-RingImidesImmunologic FactorsImmunosuppressive AgentsIsoindolesMyelosuppressive AgentsP-glycoprotein/ABCB1 SubstratesPhthalic AcidsPhthalimidesPiperidinesPiperidonesThalidomide AnalogDrug Pathways:
Cytokine-cytokine receptor interactionNF-kappa B signaling pathwayApoptosisHematopoietic cell lineageNatural killer cell mediated cytotoxicityTNF signaling pathwayProtein stability and degradationDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Lenalidomide
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |